| CAS | 1322695-34-0 |
| Sequence | H-Asp-Val-Thr-Ala-Pro-Leu-Val-Asp-Glu-Gly-Ala-Pro-Gly-Lys-Gln-Ala-Ala-Ala-Gln-Pro-His-Thr-Glu-Ile-Pro-Glu-Gly-Thr-Thr-OH |
| Sequence Single | DVTAPLVDEGAPGKQAAAQPHTEIPEGTT |
| Molecular Formula | C124H198N34O46 |
| Molecular Weight | 2901.14 |
| Technology | Synthetic |
| Storage | -20°C, avoid light, cool and dry place |
| Application | Tau Peptides |
| Description | Residue Lys87, contained in Tau Peptide (74-102) (Exon 3/Insert 2 Domain), is one of the glycation sites of PHF-tau in vitro. |
| References | 1. Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach. S.N.Thomas et al., Acta Neuropathol., 123, 105 (2012) 2. Characterization of in vitro glycation sites of tau. P.Nacharaju et al., J. Neurochem., 69, 1709 (1997) |
Tau Peptide (74-102) (Exon 3/Insert 2 Domain)
CAS No.: 1322695-34-0
Residue Lys87, contained in Tau Peptide (74-102) (Exon 3/Insert 2 Domain), is one of the glycation sites of PHF-tau in v
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.